Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 85.7 M91.1 M93.63 M91.11 M94.42 M97.8 M 376.96 M Research & development —————— — Operating income 574.08 M626.76 M627.74 M-389.41 M617.87 M722.42 M 1.58 B Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 1.06 M1.22 M1.24 M1.35 M1.25 M— — Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 13.47 M50 M39.98 M-1.17 B10.96 M22.01 M -1.1 B Equity in earnings —————— — Taxes 4.4 M12.07 M1.67 M7.84 M6.5 M9.75 M 25.76 M Non-controlling/minority interest 690 K7.81 M2.07 M279 K359 K1.33 M 4.04 M After tax other income/expense -73 K-1.05 M-779 K284 K-401 K— — Net income before discontinued operations 8.37 M30.13 M36.25 M-1.18 B4.11 M10.93 M -1.13 B Discontinued operations —————— — Net income 8.37 M30.13 M36.25 M-1.18 B4.11 M10.93 M -1.13 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 8.37 M30.13 M36.25 M-1.18 B4.11 M10.93 M -1.13 B Basic earnings per share (Basic EPS) 0.090.330.4-12.980.050.12 -12.41 Diluted earnings per share (Diluted EPS) 0.090.330.4-12.980.050.12 -12.41 Average basic shares outstanding 91.65 M90.33 M90.41 M90.7 M90.53 M90.67 M — Diluted shares outstanding 92.04 M90.44 M90.58 M90.7 M90.86 M91.2 M — EBITDA 43.71 M16.09 M4.6 M-1.21 B-26.11 M— — EBIT -15.71 M14.87 M3.37 M-1.21 B-27.37 M60.19 M -1.17 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.06 M1.22 M1.24 M1.35 M1.25 M— —